Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

The Lancet

Volumn 339, Issue 8785, 1992, Pages 89-91

  Braegger, C P ^a   Nicholls, S ^a   Murch, S H ^a   MacDonald, T T ^a   Stephens, S ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CAMPYLOBACTER JEJUNI; CHILD; CROHN DISEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; HUMAN; INFLAMMATORY BOWEL DISEASES; PROSPECTIVE STUDIES; RECURRENCE; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0026531017     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)90999-J     Document Type: Article

References (10)

1. Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease
2. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis
3. Role of platelet activating factor in ulcerative colitis
4. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease
5. Serum concentrtations of tumor necrosis factor α in childhood chronic inflammatory bowel disease
6. Local production of tumor necrosis factor alpha in inflammatory bowel disease
7. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor &agr
8. Quantitative faecal Indium-111 labelled leucocyte excretion in the assessment of disease activity in Crohn's disease
9. Early histological changes in ulcerative colitis: a light and electron microscopic study
10. Chronic inflammatory bowel disease in childhood